A Study in Adults With Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 759 participants.

Also called NCT01421459

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 759 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01421459
  • EudraCT 2011-000828-15
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Czechia, France, Germany, Greece, Hungary, Mexico, Poland, Puerto Rico, South Korea, Spain, Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01421459. Randomized; triple masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2014-10-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study in Adults With Type 2 Diabetes
Acronym
ELEMENT 2
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
LY2963016
Intervention (Drug)
Lantus
Intervention (Drug)
OAMs
Lead sponsor
Eli Lilly and Company (class: industry)
Collaborator
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct01421459
Content hash
9540ced352500a9483eb8207162f543ffd77f8fc2cf4bfe08d55c2ea87a7338b